DK1543063T3 - Medikament levering - Google Patents
Medikament leveringInfo
- Publication number
- DK1543063T3 DK1543063T3 DK03748273T DK03748273T DK1543063T3 DK 1543063 T3 DK1543063 T3 DK 1543063T3 DK 03748273 T DK03748273 T DK 03748273T DK 03748273 T DK03748273 T DK 03748273T DK 1543063 T3 DK1543063 T3 DK 1543063T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug delivery
- relates
- delivery
- drugs
- solubilising
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
- C08G73/0213—Preparatory process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0206—Polyalkylene(poly)amines
- C08G73/0213—Preparatory process
- C08G73/0226—Quaternisation of polyalkylene(poly)amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0221942.6A GB0221942D0 (en) | 2002-09-20 | 2002-09-20 | Drug delivery |
PCT/GB2003/004036 WO2004026941A1 (en) | 2002-09-20 | 2003-09-22 | Drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1543063T3 true DK1543063T3 (da) | 2009-05-18 |
Family
ID=9944516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03748273T DK1543063T3 (da) | 2002-09-20 | 2003-09-22 | Medikament levering |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060148982A1 (da) |
EP (1) | EP1543063B1 (da) |
JP (1) | JP2006500437A (da) |
AT (1) | ATE426635T1 (da) |
AU (1) | AU2003267581A1 (da) |
CA (1) | CA2499681A1 (da) |
DE (1) | DE60326859D1 (da) |
DK (1) | DK1543063T3 (da) |
GB (1) | GB0221942D0 (da) |
SI (1) | SI1543063T1 (da) |
WO (1) | WO2004026941A1 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0422877D0 (en) * | 2004-10-14 | 2004-11-17 | Univ Glasgow | Bioactive polymers |
US8057821B2 (en) * | 2004-11-03 | 2011-11-15 | Egen, Inc. | Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
EA025295B1 (ru) | 2006-01-19 | 2016-12-30 | Элексел, Инк. | Амфифильные гребенчатые полимеры, фармацевтическая композиция и способы повышения растворимости веществ |
CN101374885A (zh) * | 2006-01-27 | 2009-02-25 | 西巴控股公司 | 聚合物抗微生物剂 |
CA2670749A1 (en) * | 2006-12-05 | 2008-06-12 | Landec Corporation | Drug delivery |
US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
EP2126020B1 (de) * | 2006-12-22 | 2011-11-23 | Basf Se | Hydrophob modifizierte polyalkylenimine als farbübertragungsinhibitoren |
US9770442B2 (en) * | 2007-07-19 | 2017-09-26 | Allexcel Inc. | Self-assembling amphiphilic polymers as anti-cancer agents |
US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
FR2928373B1 (fr) | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
GB0903559D0 (en) | 2009-03-02 | 2009-04-08 | Univ London Pharmacy | Oral delivery of hydrophilic drugs to the brain |
EP2424581B1 (en) | 2009-04-28 | 2017-03-01 | SurModics, Inc. | Devices and methods for delivery of bioactive agents |
GB0915449D0 (en) | 2009-09-04 | 2009-10-07 | Univ Robert Gordon | Composition |
CA3000077A1 (en) * | 2010-04-28 | 2011-11-10 | University Of Georgia Research Foundation, Inc. | Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers |
US8721936B2 (en) | 2011-04-21 | 2014-05-13 | University Of Georgia Research Foundation, Inc. | Devices and methods for forming non-spherical particles |
US9861727B2 (en) | 2011-05-20 | 2018-01-09 | Surmodics, Inc. | Delivery of hydrophobic active agent particles |
US10213529B2 (en) | 2011-05-20 | 2019-02-26 | Surmodics, Inc. | Delivery of coated hydrophobic active agent particles |
CA2841000C (en) | 2011-07-15 | 2020-02-25 | University Of Georgia Research Foundation, Inc. | Permanent attachment of agents to surfaces containing c-h functionality |
WO2013019918A2 (en) | 2011-08-04 | 2013-02-07 | The University Of Georgia Research Foundation, Inc. | Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality |
WO2013056007A2 (en) | 2011-10-14 | 2013-04-18 | University Of Georgia Research Foundation, Inc. | Photochemical cross-linkable polymers, methods of making photochemical cross-linkable plolymers, methods of using photochemical cross-linkable poloymers, and methods of making articles containing photochemical cross-linkable polymers |
US11246963B2 (en) | 2012-11-05 | 2022-02-15 | Surmodics, Inc. | Compositions and methods for delivery of hydrophobic active agents |
CA2890205C (en) * | 2012-11-05 | 2020-12-22 | Surmodics, Inc. | Composition and method for delivery of hydrophobic active agents |
US10898446B2 (en) | 2016-12-20 | 2021-01-26 | Surmodics, Inc. | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces |
JP2021065776A (ja) * | 2021-02-04 | 2021-04-30 | 株式会社三洋物産 | 遊技機 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5879022A (ja) * | 1981-11-04 | 1983-05-12 | Bitamin Kenkyusho:Kk | 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤 |
US5338532A (en) * | 1986-08-18 | 1994-08-16 | The Dow Chemical Company | Starburst conjugates |
US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
JPH01236240A (ja) * | 1989-01-14 | 1989-09-21 | Miyoshi Oil & Fat Co Ltd | 新規な高分子化合物 |
DE3901527A1 (de) * | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
JP3406970B2 (ja) * | 1993-12-27 | 2003-05-19 | ミヨシ油脂株式会社 | 両性界面活性剤 |
JP3526661B2 (ja) * | 1995-06-23 | 2004-05-17 | ミヨシ油脂株式会社 | 抗菌剤、抗菌性樹脂及び抗菌性塗料 |
EP0912493A1 (en) * | 1996-06-19 | 1999-05-06 | The Procter & Gamble Company | Process for removing malodors from modified polyamines |
CA2321200A1 (en) * | 1998-02-27 | 1999-09-02 | Dnavec Research Inc. | Composition for transporting negatively charged substances |
JP3523821B2 (ja) * | 2000-02-09 | 2004-04-26 | ナノキャリア株式会社 | 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物 |
US6696038B1 (en) * | 2000-09-14 | 2004-02-24 | Expression Genetics, Inc. | Cationic lipopolymer as biocompatible gene delivery agent |
AU2001289943A1 (en) * | 2000-10-09 | 2002-04-22 | Bayer Aktiengesellschaft | Complexes for transferring nucleic acids into cells |
DE10065710A1 (de) * | 2000-12-29 | 2002-07-04 | Bayer Ag | Arzneimittel enthaltend ein Polyamin als Wirksubstanz |
GB0221941D0 (en) * | 2002-09-20 | 2002-10-30 | Univ Strathclyde | Polysoaps |
-
2002
- 2002-09-20 GB GBGB0221942.6A patent/GB0221942D0/en not_active Ceased
-
2003
- 2003-09-22 SI SI200331599T patent/SI1543063T1/sl unknown
- 2003-09-22 JP JP2004537295A patent/JP2006500437A/ja active Pending
- 2003-09-22 AT AT03748273T patent/ATE426635T1/de not_active IP Right Cessation
- 2003-09-22 AU AU2003267581A patent/AU2003267581A1/en not_active Abandoned
- 2003-09-22 WO PCT/GB2003/004036 patent/WO2004026941A1/en active Application Filing
- 2003-09-22 EP EP03748273A patent/EP1543063B1/en not_active Expired - Lifetime
- 2003-09-22 CA CA002499681A patent/CA2499681A1/en not_active Abandoned
- 2003-09-22 DE DE60326859T patent/DE60326859D1/de not_active Expired - Lifetime
- 2003-09-22 US US10/528,602 patent/US20060148982A1/en not_active Abandoned
- 2003-09-22 DK DK03748273T patent/DK1543063T3/da active
Also Published As
Publication number | Publication date |
---|---|
WO2004026941A1 (en) | 2004-04-01 |
ATE426635T1 (de) | 2009-04-15 |
DE60326859D1 (de) | 2009-05-07 |
AU2003267581A8 (en) | 2004-04-08 |
JP2006500437A (ja) | 2006-01-05 |
SI1543063T1 (sl) | 2009-08-31 |
CA2499681A1 (en) | 2004-04-01 |
US20060148982A1 (en) | 2006-07-06 |
EP1543063A1 (en) | 2005-06-22 |
GB0221942D0 (en) | 2002-10-30 |
EP1543063B1 (en) | 2009-03-25 |
AU2003267581A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1543063T3 (da) | Medikament levering | |
CY1118496T1 (el) | Φαρμακεyτικες συνθεσεις | |
CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
CY1112946T1 (el) | 4-υδροξυβενζομορφανια | |
BRPI0514293A (pt) | sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga | |
CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
EA200301250A1 (ru) | Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры | |
EA200600877A1 (ru) | Наночастицы для доставки лекарств | |
TW200642704A (en) | Oral drug delivery system and methods of use thereof | |
HK1118011A1 (zh) | 透明質酸的抗腫瘤生物結合物或以化學接合方法間接地取得的衍生物,以及其製藥用途 | |
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
BR0308486A (pt) | Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga | |
CY1108854T1 (el) | Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης | |
DE602005011818D1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
DE602004021713D1 (de) | Pharmazeutische formulierungen mit kurzketten-sphingolipiden und ihre verwendung | |
NO20076120L (no) | Stabile nanopartikkelformuleringer | |
EA200501301A1 (ru) | Ментоловые растворы лекарственных препаратов | |
ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol |